Immediate Impact
71 standout
Citing Papers
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
2023 Standout
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2023 Standout
Works of Chunshen Pan being referenced
Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies
2013
Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chunshen Pan | 279 | 74 | 33 | 43 | 20 | 321 | |
| Mads Faurby | 147 | 29 | 44 | 67 | 29 | 252 | |
| Annie Nikolajsen | 322 | 22 | 79 | 53 | 18 | 358 | |
| Nicoletta Musacchio | 176 | 22 | 47 | 20 | 19 | 324 | |
| Luc Sauriol | 184 | 15 | 36 | 22 | 24 | 344 | |
| Jorge Puelles | 84 | 22 | 56 | 33 | 33 | 337 | |
| Toshinari Asakura | 282 | 33 | 42 | 40 | 24 | 367 | |
| Sara Artola | 198 | 11 | 28 | 34 | 27 | 308 | |
| Maureen Clement | 283 | 13 | 66 | 80 | 15 | 371 | |
| E Stridde | 250 | 15 | 52 | 64 | 14 | 339 | |
| James LaSalle | 190 | 15 | 84 | 56 | 14 | 270 |
All Works
Loading papers...